Logo for Adaptive Biotechnologies
Logo for Adaptive Biotechnologies
  • Investors
  • |
  • Join Our Team
  • Immune Medicine
    Immune Medicine Platform
    The Adaptive Immune System
    Research Publications
  • Products & Pipeline
    Life Sciences Research
    immunoSEQ
    immunoSEQ T-MAP
    Clinical Diagnostics
    clonoSEQ
    T-Detect
    Drug Discovery
    Cellular Therapy
    Neutralizing Antibodies
    Vaccines
    Pipeline
    Clinical Portfolio & Pipeline
    Partners
    Biopharma Partners
    Technology Partners
  • News & Events
    MEDIA
    Press Releases
    Media Resources
    BLOG
    New T-Detect COVID test
    Julie Rubinstein Reflects on World Cancer Day
    Learnings from the COVID-19 Immune Response Will Accelerate Healthcare Innovation
    Powering the Age of Immune Medicine
    See all posts
    events
    Conferences & Events
    Webinars
  • Our Science
    Clinical Studies
    ImmuneRACE
    ImmuneSense Lyme
    medical
    Medical Affairs
    Medical Information
    Data & Congresses
    DATA PROGRAMS
    ImmuneCODE
    ImmuneACCESS
    PUBLICATIONS
    Research Publications
    EDUCATION
    SEQdiscovery
  • About Us
    ABOUT US
    Who We Are
    Our Story
    Innovation Timeline
    Leadership
    INVESTORS
    Investor Relations
    Newsroom
    CONNECT
    Contact
    Careers
  • IMMUNE MEDICINE
    • Immune Medicine Platform
    • The Adaptive Immune System
    • Research Publications
  • PRODUCTS & PIPELINE
    • LIFE SCIENCES RESEARCH
    • immunoSEQ
    • immunoSEQ T-MAP
    • CLINICAL DIAGNOSTICS
    • clonoSEQ
    • T-Detect
    • DRUG DISCOVERY
    • Cellular Therapy
    • Neutralizing Antibodies
    • Vaccines
    • PIPELINE
    • Clinical Portfolio & Pipeline
    • PARTNERS
    • Biopharma Partners
    • Technology Partners
  • NEWS & EVENTS
    • MEDIA
    • Press Releases
    • Media Resources
    • BLOG
    • New T-Detect COVID test
    • Julie Rubinstein Reflects on World Cancer Day
    • Learnings from the COVID-19 Immune Response Will Accelerate Healthcare Innovation
    • Powering the Age of Immune Medicine
    • See all posts ➔
    • EVENTS
    • Conferences & Events
    • Webinars
  • OUR SCIENCE
    • CLINICAL
    • ImmuneRACE
    • ImmuneSense Lyme
    • MEDICAL
    • Medical Affairs
    • Medical Information
    • Data & Congresses
    • DATA PROGRAMS
    • ImmuneCODE
    • ImmuneACCESS
    • PUBLICATIONS
    • Research Publications
    • EDUCATION
    • SEQdiscovery
  • ABOUT US
    • ABOUT US
    • Who We Are
    • Our Story
    • Innovation Timeline
    • Leadership
    • INVESTORS
    • Investor Relations
    • Newsroom
    • CONNECT
    • Contact
    • Careers
Menu
  • IMMUNE MEDICINE
    • Immune Medicine Platform
    • The Adaptive Immune System
    • Research Publications
  • PRODUCTS & PIPELINE
    • LIFE SCIENCES RESEARCH
    • immunoSEQ
    • immunoSEQ T-MAP
    • CLINICAL DIAGNOSTICS
    • clonoSEQ
    • T-Detect
    • DRUG DISCOVERY
    • Cellular Therapy
    • Neutralizing Antibodies
    • Vaccines
    • PIPELINE
    • Clinical Portfolio & Pipeline
    • PARTNERS
    • Biopharma Partners
    • Technology Partners
  • NEWS & EVENTS
    • MEDIA
    • Press Releases
    • Media Resources
    • BLOG
    • New T-Detect COVID test
    • Julie Rubinstein Reflects on World Cancer Day
    • Learnings from the COVID-19 Immune Response Will Accelerate Healthcare Innovation
    • Powering the Age of Immune Medicine
    • See all posts ➔
    • EVENTS
    • Conferences & Events
    • Webinars
  • OUR SCIENCE
    • CLINICAL
    • ImmuneRACE
    • ImmuneSense Lyme
    • MEDICAL
    • Medical Affairs
    • Medical Information
    • Data & Congresses
    • DATA PROGRAMS
    • ImmuneCODE
    • ImmuneACCESS
    • PUBLICATIONS
    • Research Publications
    • EDUCATION
    • SEQdiscovery
  • ABOUT US
    • ABOUT US
    • Who We Are
    • Our Story
    • Innovation Timeline
    • Leadership
    • INVESTORS
    • Investor Relations
    • Newsroom
    • CONNECT
    • Contact
    • Careers

Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma

Read the latest
from Adaptive

Immune Medicine
  • Immune Medicine Platform
  • The Adaptive Immune
    System
  • Research Publications
Products & Platform
  • immunoSEQ
  • immunoSEQ T-MAP
  • clonoSEQ
  • T-Detect
  • Cellular Therapy
  • Neutralizing Antibodies
  • Vaccines
  • Pipeline
  • Technology Partners
  • Biopharma Partnerships
News & Events
  • Press Releases
  • Blog
  • Media Resources
  • Webinars
  • Conferences & Events
Our Science
  • ImmuneRACE
  • ImmuneSense Lyme
  • Research Publications
  • ImmuneCODE
  • ImmuneACCESS
  • Medical Affairs
  • Medical Information
  • Data & Congresses
  • SEQDiscovery
About Us
  • Who We Are
  • Our Story
  • Innovation Timeline
  • Leadership
  • Investor Relations
  • Newsroom
  • Careers
  • Contact Us
Logo for Adaptive Biotechnologies

Diagnostics (888) 552-8988 | Corporate/Research (855) 466-8667

© Adaptive Biotechnologies. All Rights Reserved. Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct
Facebook-f
Youtube
Twitter
Instagram
Linkedin-in

© Adaptive Biotechnologies. All Rights Reserved.
Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct

Logo for Adaptive Biotechnologies

Diagnostics (888) 552-8988

Corporate/Research (855) 466-8667

Facebook-f
Youtube
Twitter
Instagram
Linkedin-in

© Adaptive Biotechnologies. All Rights Reserved.

Online Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct

STAY IN TOUCH

Receive the latest

Adaptive news and updates

Your email is safe with us. Read our Privacy Policy.

Tech Meets Biotech: The new T-Detect COVID test has launched!
Read More